These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 9579642)
21. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease. Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198 [TBL] [Abstract][Full Text] [Related]
22. [High-shear force-induced platelet aggregation in the screening and diagnosis of von Willebrand disease]. Schlammadinger A; Kerényi A; Muszbek L; Boda Z Orv Hetil; 2000 Oct; 141(41):2245-50. PubMed ID: 11184249 [TBL] [Abstract][Full Text] [Related]
23. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977 [TBL] [Abstract][Full Text] [Related]
24. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100. Cesar JM; de Miguel D; García Avello A; Burgaleta C Am J Clin Pathol; 2005 May; 123(5):772-7. PubMed ID: 15981818 [TBL] [Abstract][Full Text] [Related]
25. Assessment of platelet adhesiveness and aggregation in mild acute pancreatitis using the PFA-100 system. Mimidis K; Papadopoulos V; Kartasis Z; Baka M; Tsatlidis V; Bourikas G; Kartalis G JOP; 2004 May; 5(3):132-7. PubMed ID: 15138334 [TBL] [Abstract][Full Text] [Related]
27. [New in vitro analysis tested: bleeding time is still the best method for evaluation of primary hemostasis]. Ridefelt P; Egberg N; Hillarp A; Lethagen S; Tengborn L Lakartidningen; 2001 Sep; 98(37):3922-4. PubMed ID: 11586831 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of the new INNOVANCE® PFA P2Y cartridge in patients with impaired primary haemostasis. Koessler J; Ehrenschwender M; Kobsar A; Brunner K Platelets; 2012; 23(8):571-8. PubMed ID: 22185369 [TBL] [Abstract][Full Text] [Related]
29. Hemodialysis shortens long in vitro closure times as measured by the PFA-100. Bilgin AU; Karadogan I; Artac M; Kizilors A; Bligin R; Undar L Med Sci Monit; 2007 Mar; 13(3):CR141-5. PubMed ID: 17325638 [TBL] [Abstract][Full Text] [Related]
30. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618 [TBL] [Abstract][Full Text] [Related]
31. Towards a rationale of platelet aggregation monitoring in stroke prophylaxis? von Lewinski F; Riggert J; Paulus W J Stroke Cerebrovasc Dis; 2009; 18(2):111-5. PubMed ID: 19251186 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation. Escolar G; Cases A; Viñas M; Pino M; Calls J; Cirera I; Ordinas A Haematologica; 1999 Jul; 84(7):614-9. PubMed ID: 10406903 [TBL] [Abstract][Full Text] [Related]
33. Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients. Kotzailias N; Elwischger K; Sycha T; Rinner W; Quehenberger P; Auff E; Müller C J Stroke Cerebrovasc Dis; 2007; 16(5):199-202. PubMed ID: 17845916 [TBL] [Abstract][Full Text] [Related]
34. Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. Buyukasik Y; Karakus S; Goker H; Haznedaroglu IC; Ozatli D; Sayinalp N; Ozcebe OI; Dundar SV; Kirazli S Blood Coagul Fibrinolysis; 2002 Jun; 13(4):349-53. PubMed ID: 12032401 [TBL] [Abstract][Full Text] [Related]
35. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Harrison P; Robinson M; Liesner R; Khair K; Cohen H; Mackie I; Machin S Clin Lab Haematol; 2002 Aug; 24(4):225-32. PubMed ID: 12181026 [TBL] [Abstract][Full Text] [Related]
36. Screening for aspirin resistance in stable coronary artery patients by three different tests. Chakroun T; Addad F; Abderazek F; Ben-Farhat M; Hamdi S; Gamra H; Hassine M; Ben-Hamda K; Samama MM; Elalamy I Thromb Res; 2007; 121(3):413-8. PubMed ID: 17553552 [TBL] [Abstract][Full Text] [Related]
37. Can the Platelet Function Analyzer (PFA)-100 test substitute for the template bleeding time in routine clinical practice? Francis J; Francis D; Larson L; Helms E; Garcia M Platelets; 1999; 10(2-3):132-6. PubMed ID: 16801082 [TBL] [Abstract][Full Text] [Related]
38. Variation in platelet function testing has a major influence on detection of aspirin resistance in healthy subjects. Bozic-Mijovski M; Rakusa M; Stegnar M Pathophysiol Haemost Thromb; 2008; 36(2):84-90. PubMed ID: 19127088 [TBL] [Abstract][Full Text] [Related]
39. Using the Platelet Function Analyzer-100 for monitoring aspirin therapy. Poulsen TS; Mickley H; Korsholm L; Licht PB; Haghfelt T; Jørgensen B Thromb Res; 2007; 120(2):161-72. PubMed ID: 17052745 [TBL] [Abstract][Full Text] [Related]
40. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders. Favaloro EJ; Facey D; Henniker A Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]